This is a StreetInsider.com Premium Only Page

Athersys (ATHX) –

Apr 5, 2024 04:17 PM Form 8-K ATHERSYS, INC / NEW For: Apr 01

Apr 1, 2024 06:41 AM Form NT 10-K ATHERSYS, INC / NEW For: Dec 31

Jan 8, 2024 07:31 AM Form 8-K ATHERSYS, INC / NEW For: Jan 05

Dec 27, 2023 09:01 AM Form 25-NSE ATHERSYS, INC / NEW Filed by: Nasdaq Stock Market LLC

Dec 22, 2023 05:09 PM Form 8-K ATHERSYS, INC / NEW For: Dec 20

Dec 21, 2023 11:37 AM Form 4 ATHERSYS, INC / NEW For: Dec 18 Filed by: Hansen Maia

Dec 4, 2023 07:28 AM Form 424B3 ATHERSYS, INC / NEW

Nov 30, 2023 06:04 AM Form EFFECT ATHERSYS, INC / NEW

Nov 22, 2023 06:02 AM Form S-1/A ATHERSYS, INC / NEW

Nov 17, 2023 06:36 AM Athersys (ATHX) Tops Q3 EPS by 6c

Nov 16, 2023 08:35 AM Form 10-Q ATHERSYS, INC / NEW For: Sep 30

Nov 16, 2023 08:30 AM Athersys Reports Third Quarter 2023 Financial Results and Business Highlights

Nov 14, 2023 07:30 PM Form NT 10-Q ATHERSYS, INC / NEW For: Sep 30

Nov 9, 2023 05:15 PM Athersys (ATHX) Announces 76.25M Share Offering by Selling Stockholders

Nov 9, 2023 05:10 PM Form S-1 ATHERSYS, INC / NEW

Oct 30, 2023 04:30 PM Form 8-K ATHERSYS, INC / NEW For: Oct 30

Oct 18, 2023 08:00 AM Form 8-K ATHERSYS, INC / NEW For: Oct 13

Oct 16, 2023 04:52 PM Athersys (ATHX) Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives

Oct 16, 2023 04:52 PM Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives

Oct 12, 2023 09:29 AM Form 8-K ATHERSYS, INC / NEW For: Oct 11

Oct 11, 2023 09:28 AM Form 8-K ATHERSYS, INC / NEW For: Oct 10

Oct 10, 2023 08:30 AM Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios

Oct 10, 2023 08:25 AM Athersys (ATHX) Halted, News Pending

Oct 6, 2023 05:35 PM Form 4 ATHERSYS, INC / NEW For: Oct 04 Filed by: Hansen Maia

Oct 6, 2023 05:28 PM Form 4 ATHERSYS, INC / NEW For: Oct 04 Filed by: Camardo Daniel A.

Oct 3, 2023 04:42 PM Form 8-K ATHERSYS, INC / NEW For: Oct 02

Oct 3, 2023 04:31 PM Athersys (ATHX) Licenses Animal Health Assets to Ardent Animal Health

Oct 3, 2023 04:30 PM Athersys Licenses its Animal Health Assets to Ardent Animal Health

Oct 2, 2023 05:06 PM Athersys (ATHX) Director Jane Wasman Appointed Board Chair

Oct 2, 2023 05:06 PM Form 8-K ATHERSYS, INC / NEW For: Sep 27

Oct 2, 2023 05:04 PM Athersys Director Jane Wasman Appointed Board Chair

Sep 25, 2023 04:37 PM Form 424B3 ATHERSYS, INC / NEW

Sep 22, 2023 06:04 AM Form EFFECT ATHERSYS, INC / NEW

Sep 19, 2023 12:28 PM Form 4 ATHERSYS, INC / NEW For: Sep 18 Filed by: Hansen Maia

Sep 19, 2023 06:03 AM Form DEFA14A ATHERSYS, INC / NEW

Sep 19, 2023 06:03 AM Form 8-K ATHERSYS, INC / NEW For: Sep 18

Sep 14, 2023 11:01 AM Form 4 ATHERSYS, INC / NEW For: Aug 17 Filed by: MAYHUGH NEEMA

Sep 14, 2023 10:41 AM Form 3 ATHERSYS, INC / NEW For: Aug 17 Filed by: MAYHUGH NEEMA

Sep 13, 2023 05:16 PM Athersys (ATHX) Announces 15.36M Share Offering by Selling Stockholders

Sep 13, 2023 05:14 PM Form S-3 ATHERSYS, INC / NEW

Sep 11, 2023 08:47 AM Form 8-K ATHERSYS, INC / NEW For: Sep 08

Sep 6, 2023 02:45 PM Grant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney Transplantation

Aug 21, 2023 02:37 PM Form 424B4 ATHERSYS, INC / NEW

Aug 18, 2023 10:14 AM Form 8-K ATHERSYS, INC / NEW For: Aug 17

Aug 18, 2023 05:42 AM Athersys (ATHX) Prices 10.94M Share Offering at $0.32/sh

Aug 17, 2023 09:30 PM Athersys, Inc. Announces Pricing of $3.5 Million Public Offering

Aug 17, 2023 04:16 PM Form DEF 14A ATHERSYS, INC / NEW For: Sep 27

Aug 16, 2023 05:33 PM Athersys (ATHX) Misses Q2 EPS by 33c

Aug 16, 2023 05:06 PM Form 10-Q ATHERSYS, INC / NEW For: Jun 30

Aug 16, 2023 05:01 PM Athersys (ATHX) Reports Q2, Provides Updates